These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1011 related articles for article (PubMed ID: 27856810)

  • 21. The role of physical activity in chronic kidney disease in the presence of diabetes mellitus: a prospective cohort study.
    Wang IK; Tsai MK; Liang CC; Yen TH; Huang CC; Wen SF; Wen CP
    Am J Nephrol; 2013; 38(6):509-16. PubMed ID: 24356340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study.
    Kokubo Y; Okamura T; Watanabe M; Higashiyama A; Ono Y; Miyamoto Y; Furukawa Y; Kamide K; Kawanishi K; Okayama A; Yoshimasa Y
    Hypertens Res; 2010 Dec; 33(12):1238-43. PubMed ID: 20927111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years.
    Rashidi A; Sehgal AR; Rahman M; O'Connor AS
    Am J Cardiol; 2008 Dec; 102(12):1668-73. PubMed ID: 19064021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of chronic kidney disease on hospitalization, chronic dialysis, and mortality in Japanese men: a longitudinal analysis.
    Nishikawa K; Takahashi K; Yamada R; Kinaga T; Masato M; Yamamoto M
    Clin Exp Nephrol; 2017 Apr; 21(2):316-323. PubMed ID: 27339450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking increases the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease.
    Nakamura K; Nakagawa H; Murakami Y; Kitamura A; Kiyama M; Sakata K; Tsuji I; Miura K; Ueshima H; Okamura T;
    Kidney Int; 2015 Nov; 88(5):1144-52. PubMed ID: 26200944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study.
    Hutton HL; Levin A; Gill J; Djurdjev O; Tang M; Barbour SJ
    BMC Nephrol; 2017 Mar; 18(1):95. PubMed ID: 28320366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Population attributable fraction of smoking and metabolic syndrome on cardiovascular disease mortality in Japan: a 15-year follow up of NIPPON DATA90.
    Takashima N; Miura K; Hozawa A; Kadota A; Okamura T; Nakamura Y; Hayakawa T; Okuda N; Fujiyoshi A; Nagasawa SY; Kadowaki T; Murakami Y; Kita Y; Okayama A; Ueshima H;
    BMC Public Health; 2010 Jun; 10():306. PubMed ID: 20525280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of diabetes mellitus or cardiovascular disease and lifestyle changes - the Doetinchem cohort study.
    Manschot A; van Oostrom SH; Smit HA; Verschuren WM; Picavet HS
    Prev Med; 2014 Feb; 59():42-6. PubMed ID: 24275227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of High Ankle Brachial Index With Incident Cardiovascular Disease and Mortality in a High-Risk Population.
    Hendriks EJ; Westerink J; de Jong PA; de Borst GJ; Nathoe HM; Mali WP; van der Graaf Y; van der Schouw YT; Beulens JW;
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):412-7. PubMed ID: 26715681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort.
    Yokomichi H; Nagai A; Hirata M; Kiyohara Y; Muto K; Ninomiya T; Matsuda K; Kamatani Y; Tamakoshi A; Kubo M; Nakamura Y; ; Yamagata Z
    J Epidemiol; 2017 Mar; 27(3S):S98-S106. PubMed ID: 28209242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV/HCV-coinfected patients who achieved sustained virological response.
    Leone S; Prosperi M; Costarelli S; Nasta P; Maggiolo F; Di Giambenedetto S; Saracino A; Di Pietro M; Gori A
    Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1511-20. PubMed ID: 27272121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac troponin T elevation at dialysis initiation is associated with all-cause and cardiovascular mortality on dialysis in patients without diabetic nephropathy.
    Hayashi T; Kimura T; Yasuda K; Sasaki K; Obi Y; Rakugi H; Isaka Y
    Clin Exp Nephrol; 2017 Apr; 21(2):333-341. PubMed ID: 27178276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE).
    Yuan J; Zou XR; Han SP; Cheng H; Wang L; Wang JW; Zhang LX; Zhao MH; Wang XQ;
    BMC Nephrol; 2017 Jan; 18(1):23. PubMed ID: 28088175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global cardiovascular mortality risk in the adult Polish population: prospective assessment of the cohorts studied in multicentre national WOBASZ and WOBASZ Senior studies.
    Piotrowski W; Waśkiewicz A; Cicha-Mikołajczyk A
    Kardiol Pol; 2016; 74(3):262-73. PubMed ID: 26365939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Relation Between Severity of Diabetes Mellitus (On or Off Insulin) ± Chronic Kidney Disease with Cardiovascular Risk After Percutaneous Coronary Intervention.
    Chamaria S; Bhatheja S; Vengrenyuk Y; Sweeny J; Choudhury H; Barman N; Mehran R; Sharma S; Baber U; Kini A
    Am J Cardiol; 2018 Jan; 121(2):168-176. PubMed ID: 29187288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study.
    Hadaegh F; Derakhshan A; Mozaffary A; Hasheminia M; Khalili D; Azizi F
    PLoS One; 2016; 11(3):e0149780. PubMed ID: 26930192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of cardiovascular health metrics with all-cause and cardiovascular disease mortality in chronic kidney disease: A cohort study.
    Zhang S; Xue Q; Li D; Xu Y; Zhang YB; Peng J; Wu S; He X; Yang X; Liu Y; Yan T; Wu N; Wen Y; Cravens L; Wu JH; Yang CX; Pan XF
    Nutr Metab Cardiovasc Dis; 2024 Aug; 34(8):1837-1845. PubMed ID: 38760189
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Joint impact of smoking and hypertension on cardiovascular disease and all-cause mortality in Japan: NIPPON DATA80, a 19-year follow-up.
    Hozawa A; Okamura T; Murakami Y; Kadowaki T; Nakamura K; Hayakawa T; Kita Y; Nakamura Y; Abbott RD; Okayama A; Ueshima H;
    Hypertens Res; 2007 Dec; 30(12):1169-75. PubMed ID: 18344621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.